Vitamin B3 cream may shield transplant patients from skin cancer
NCT ID NCT07286318
First seen Jan 07, 2026 · Last updated May 16, 2026 · Updated 21 times
Summary
This study tests whether a daily cream containing 5% niacinamide (a form of vitamin B3) can help prevent skin cancer in organ transplant recipients. These patients have a much higher risk of skin cancer due to long-term immune-suppressing drugs. The study will compare the cream plus sunscreen against sunscreen alone in 20 adults over 12 months, tracking precancerous spots and new skin cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UPMC Falk Dermatology
Pittsburgh, Pennsylvania, 15213, United States
-
UPMC St Margarets Dermatology
Pittsburgh, Pennsylvania, 15238, United States
Conditions
Explore the condition pages connected to this study.